Maria Bedoya-Toro Munera
General Counsel at DERMATA THERAPEUTICS, INC.
Net worth: 2 436 $ as of 29/04/2024
Profile
Maria Bedoya-Toro Munera is currently the Senior VP-Regulatory Affairs & Quality Assurance at Dermata Therapeutics, Inc. She previously held positions at Amylin Pharmaceuticals, Inc., Ligand Pharmaceuticals, Inc., Eisai Medical Research, Inc., Baxter Hyland Immuno, BASF Bioresearch Corp., Santarus, Inc., and Receptos LLC.
Bedoya-Toro Munera has an MBA from The University of Chicago, a doctorate from The Ohio University, and undergraduate and graduate degrees from Western Michigan University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 03/01/2024 | 7,164 ( 0.11% ) | 2 436 $ | 29/04/2024 |
Maria Bedoya-Toro Munera active positions
| Companies | Position | Start |
|---|---|---|
| DERMATA THERAPEUTICS, INC. | General Counsel | 31/12/2015 |
Former positions of Maria Bedoya-Toro Munera
| Companies | Position | End |
|---|---|---|
| RECEPTOS INC | General Counsel | 31/12/2014 |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | General Counsel | 01/01/2014 |
| Eisai Medical Research, Inc. | General Counsel | 30/04/2007 |
| LIGAND PHARMACEUTICALS INCORPORATED | General Counsel | 31/12/2005 |
| Baxter Hyland Immuno | General Counsel | 31/12/2002 |
Training of Maria Bedoya-Toro Munera
| The University of Chicago | Masters Business Admin |
| The Ohio University | Doctorate Degree |
| Western Michigan University | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| Private companies | 7 |
|---|---|
Santarus, Inc.
Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Health Technology |
| Eisai Medical Research, Inc. | |
| Baxter Hyland Immuno | |
| BASF Bioresearch Corp. | |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
| Dermata Therapeutics, Inc. | |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Maria Bedoya-Toro Munera
